Sana Biotechnology Inc’s recently made public that its Officer CHRISTIAN HORDO & KATHARINE HO acquired Company’s shares for reported $0.24 million on Feb 18 ’25. In the deal valued at $3.16 per share,75,000 shares were bought.
Then, CHRISTIAN HORDO & KATHARINE HO bought 75,000 shares, generating $289,500 in total proceeds.
Before that, FMR LLC sold 290,912 shares. Sana Biotechnology Inc shares valued at $1,887,320 were divested by the See Remark 1 at a price of $6.49 per share. As a result of the transaction, FMR LLC now holds 4,541,511 shares, worth roughly $13.72 million.
TD Cowen upgraded its Sana Biotechnology Inc [SANA] rating to a Buy from a a Hold in a research note published recently. A number of analysts have revised their coverage, including JMP Securities’s analysts, who decreased its forecast for the stock in early November from “a Mkt outperform” to “a Mkt perform”. Rodman & Renshaw began covering SANA with “Buy” recommendation on June 26, 2024. H.C. Wainwright revised its rating on January 16, 2024. It rated SANA as “a Buy” which previously was an “a Neutral”.
Price Performance Review of SANA
On Tuesday, Sana Biotechnology Inc [NASDAQ:SANA] saw its stock fall -4.43% to $3.02. Over the last five days, the stock has gained 10.42%. Sana Biotechnology Inc shares have risen nearly 85.28% since the year began. Nevertheless, the stocks have fallen -58.17% over the past one year. While a 52-week high of $12.00 was reached on 01/08/25, a 52-week low of $1.52 was recorded on 01/02/25. SMA at 50 days reached $2.65, while 200 days put it at $4.66.
Levels Of Support And Resistance For SANA Stock
The 24-hour chart illustrates a support level at 2.90, which if violated will result in even more drops to 2.79. On the upside, there is a resistance level at 3.24. A further resistance level may holdings at 3.47. The Relative Strength Index (RSI) on the 14-day chart is 50.63, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.08, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 58.33%. Stochastics %K at 50.31% indicates the stock is a holding.
The most recent change occurred on September 25, 2023 when JMP Securities began covering the stock and recommended ‘”a Mkt outperform”‘ rating along with a $9 price target.
